Machine learning and experimental validation of novel biomarkers for hypertrophic cardiomyopathy and cancers

Documenti analoghi

• Machine learning and deep learning to identifying subarachnoid haemorrhage macrophage‐associated biomarkers by bulk and single‐cell sequencing
  di: Sha Yang, et al.
  Pubblicazione: (2024)
• Identification of necroptosis‐related genes in ankylosing spondylitis by bioinformatics and experimental validation
  di: Pengfei Wen, et al.
  Pubblicazione: (2024)
• Beyond biomarkers: Exploring the diverse potential of a novel phosphoprotein in lung cancer management
  di: Amirabbas Rostami, et al.
  Pubblicazione: (2024)
• Post‐translational modifications in diabetic cardiomyopathy
  di: Zhi Li, et al.
  Pubblicazione: (2024)
• A novel mitochondria‐related core gene signature to predict the prognosis and evaluate tumour microenvironment in CESC single‐cell validation
  di: Lingxiao Ying, et al.
  Pubblicazione: (2024)